DRAP Declares Multiple Syringe Batches Substandard, Issues Nationwide Health Alert

Islamabad: The Drug Regulatory Authority of Pakistan (DRAP) has issued a nationwide medical product alert after declaring several batches of auto-disable syringes manufactured by local and international companies as substandard. The regulator has warned healthcare providers and the public against using the affected products due to serious safety concerns.

According to Beyond Time News, laboratory testing revealed that certain 3ml and 5ml auto-disable syringes failed to meet essential quality standards designed to prevent reuse, raising concerns about the potential spread of infectious diseases.

Quality Tests Reveal Safety Concerns

The action follows an investigation conducted by the Central Drugs Laboratory in Karachi. During routine quality assessments, officials tested multiple syringe samples and found that several batches did not comply with the required auto-disable functionality standards.

Auto-disable syringes are specifically designed to lock after a single use, preventing reuse and reducing the risk of transmitting blood-borne infections. However, the affected products reportedly contained defects that could allow repeated use.

Local and International Manufacturers Affected

According to DRAP, the substandard batches include products manufactured by companies based in Pakistan, China, and Egypt.

Among the identified manufacturers are:

• Jiangxi Fenglin Medical Appliances, China
• Medila Elwakia International Company, Egypt
• Shandong Care Medical, China
• Additional manufacturers operating in Punjab and Khyber Pakhtunkhwa

The regulator stated that both imported and locally supplied syringe batches were found to have quality deficiencies during testing.

Public Health Risks Highlighted

Health authorities have expressed concern that malfunctioning auto-disable syringes could increase the risk of transmitting serious infectious diseases.

DRAP warned that the reuse of syringes can contribute to the spread of:

• Hepatitis B
• Hepatitis C
• HIV/AIDS
• Other blood-borne infections

The authority emphasized that safe injection practices remain a critical component of public health protection and disease prevention.

Immediate Ban and Product Recall Ordered

Following the findings, DRAP has prohibited the sale, distribution, and use of the affected syringe batches across Pakistan.

The authority has also directed:

• Provincial health departments to remove the products from circulation.
• Healthcare facilities to stop using the identified batches immediately.
• Manufacturers, importers, and distributors to initiate product recalls.
• Regulatory teams to monitor compliance and ensure market withdrawal.

Officials have instructed provincial authorities to take urgent action to prevent the continued use of the affected medical devices.

Read more:Banned Syringes Still Circulating Despite Nationwide Prohibition

Healthcare Facilities Urged to Exercise Caution

Medical institutions, pharmacies, and healthcare professionals have been advised to verify their inventory and ensure that none of the affected syringe batches remain in use.

Experts stress that strict adherence to quality standards for medical devices is essential to maintaining patient safety and preventing avoidable health risks.

Conclusion

DRAP’s latest alert highlights the importance of rigorous quality control within Pakistan’s healthcare system. By identifying and removing defective syringe batches from the market, health authorities aim to reduce the risk of infection and protect public health. Healthcare providers and distributors are encouraged to cooperate fully with recall efforts and follow all regulatory directives to ensure patient safety.

FAQs

Why did DRAP issue an alert about these syringes?

DRAP issued the alert after laboratory tests found that several syringe batches failed to meet auto-disable safety standards.

What is an auto-disable syringe?

An auto-disable syringe is designed for single use and automatically locks after injection to prevent reuse.

What health risks are associated with defective syringes?

Defective syringes may increase the risk of transmitting infections such as hepatitis B, hepatitis C, and HIV if reused.

Has DRAP banned the affected syringe batches?

Yes. DRAP has prohibited the sale, distribution, and use of the identified batches and ordered their recall.

What should healthcare providers do?

Hospitals, clinics, and pharmacies should immediately stop using the affected products and follow recall instructions issued by the authorities.

#DRAP #PakistanHealth #MedicalAlert #SyringeRecall #HealthcareSafety #PublicHealth #PakistanNews #HealthUpdate